Role of probiotics in Helicobacter pylori infections

References

• Isolauri E. Probiotics in human disease. Am J Clin Nutr 2001; 73: 1142–6S.
   PubMed Web of Science ®Google Scholar
• Fuller R. Probiotics in human medicine. Gut 1991; 32: 439–42.
   PubMed Web of Science ®Google Scholar
• Metchnikoff E. The prolongation of life. London: Heinemann; 1907.
   Google Scholar
• Go MF. Review Article: Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(Suppl 1): 3–15.
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175–86.
   PubMed Web of Science ®Google Scholar
• Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994; 35: 742–5.
   PubMed Web of Science ®Google Scholar
• Cremonini F, Gasbarrini A, Armuzzi A, Gasbarrini G. Helicobacter pylorirelated diseases. Eur J Clin Invest 2001; 31: 431–7.
   PubMedGoogle Scholar
• Malfertheiner P, Megraud F, O’Morain C, Hungin AP, Jones R, Axon A, et al. European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2–2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167–80.
   Google Scholar
• Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torre ES, et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999; 45(Suppl 1): 19–12.
   Google Scholar
• Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUAD-RATE study. Gastroenterology 2002; 123: 1763–9.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Pajares JM. Review Article: Helicobacter pylori infection and gastric outlet obstruction - pre-valence of the infection and role of antimicrobial treatment. Aliment Pharmacol Ther 2002; 16: 1203–8.
   PubMedGoogle Scholar
• Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130(2S Suppl): 396–402S.
   Google Scholar
• Reid G, Bruce AW, Cook RL. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 1987; 138: 330–5.
   PubMed Web of Science ®Google Scholar
• Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987; 70: 1–12.
   PubMed Web of Science ®Google Scholar
• Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) Lal on Helicobacter pylori infection in humans. Digestion 1999; 60: 203–9.
   PubMed Web of Science ®Google Scholar
• Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 4573–80.
   PubMed Web of Science ®Google Scholar
• Lorca GL, Wadstrom T, Valdez GF, Ljungh A. Lacto-bacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 2001; 42: 39–44.
   PubMed Web of Science ®Google Scholar
• Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lacto-bacilli in a gnotobiotic murine model. Gut 1997; 41: 49–55.
   PubMed Web of Science ®Google Scholar
• Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93: 2097–101.
   PubMed Web of Science ®Google Scholar
• Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri . FEMS Immunol Med Microbiol 2002; 32: 105–10.
   PubMedGoogle Scholar
• Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, et al. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 2001; 45: 3156–61.
   PubMed Web of Science ®Google Scholar
• Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001; 13: 25–9.
   PubMed Web of Science ®Google Scholar
• Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001; 47: 709–10.
   PubMed Web of Science ®Google Scholar
• Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14: 1625–9.
   PubMed Web of Science ®Google Scholar
• Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, et al. Impact of supplement with Lactobacillus-and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669–75.
   PubMed Web of Science ®Google Scholar
• Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993; 12: 207–20.
   PubMed Web of Science ®Google Scholar
• Nord CE, Heimdal A, Kager L. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1986; 49: 64–72.
   Google Scholar
• Adamsson I, Nord CE, Lundquist P, Sjostedt S, Edlund C. Comparative effects of omeprazole, amoxycillin, plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal micro-flora in Helicobacter pyloriinfected patients. J Antimicrob Chemother 1999; 44: 629–40.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Freedman AR. Review Article: The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12: 807–22.
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1–7.
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163–9.
   PubMed Web of Science ®Google Scholar
• Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapyrelated side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744–9.
   PubMed Web of Science ®Google Scholar
• EC Nista, M Candelli, IA Cazzato, E Carloni, M Gabrielli, L Fini, et al. Impact of Bacillus clausii supplementation on anti-Helicobacter pylori therapyrelated side effects: a randomized double-blind placebo-controlled study. Gastroenterology 2003; 124 (Suppl 1): A-361 (Abstract 1498).
   Google Scholar